The discovery of FSP1 enhances the cognition of ferroptosis, which is critical for exploiting potential FSP1 inhibitors and ferroptosis-inducing drugs as strategies to overcome ferroptosis resistance in many cancers [54, 55]. This evidence concerns the gene AIFM2 and cancer.